No cure, no fee? Outcome-based agreements for gene therapies
The significant price-tags associated with gene therapies are leading to questions being raised about value for both patients and payers...
Associate director, Office of Health Economics
Amanda Cole is an associate director at the Office of Health Economics with expertise in economic evaluation and reimbursement, real–world evidence, and analysis of critical health policy issues. She is team leader for Office of Health Economics Economics of Innovation theme, and outside of the Office of Health Economics holds a visiting lecturer position at University College London and is a member of International Society for Pharmacoeconomics and Outcomes Research Health Science Policy Council.
by Nadine Henderson and 1 others
The significant price-tags associated with gene therapies are leading to questions being raised about value for both patients and payers...
BioNews, published by the Progress Educational Trust (PET), provides news and comment on genetics, assisted conception, embryo/stem cell research and related areas.